In this study, we initially found higher expression of RhoA, SRF, and MRTFA in Nogo-B overexpressing NPC cells, indicating that Nogo-B could activate the RhoA-SRF-MRTFA pathway in vitro. This evidence concerns the gene SRF and nasopharyngeal carcinoma.